ArticleScientific reports2018

T cell immunomodulation by clinically used allogeneic human cancellous bone fragments: a potential novel immunotherapy tool.

Yasser M El-Sherbiny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.